Abstract
Sodium and fluid management in the brain injured patient directly impacts cerebral edema and cerebral perfusion pressure. Sodium is a major determinant of neuronal size and therefore hyponatremia is aggressively avoided, as hypoosmolar states result in cerebral edema. Negative fluid balance is often avoided because resultant drop in cerebral perfusion pressure can contribute to cerebral ischemia, further inducing secondary neuronal injury. Patients with brain injury are at risk for disorders of sodium and fluid balance (eg, syndrome of inappropriate antidiuresis, cerebral salt wasting, and diabetes insipidus). Knowledge of normal homeostatic and brain regulatory volume mechanisms is necessary to avoid inducing further neuronal or systemic injury while trying to correct sodium and fluid disorders in brain injured patients. Osmotherapy is a common part of managing cerebral edema in neurocritical care units, but more studies are needed to establish practice guidelines.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Larive LL, Rhoney DH, Parker Jr D, et al. Introducing hypertonic saline for cerebral edema: an academic center experience. Neurocrit Care. 2004;1(4):435–40.
Raslan A, Bhardwaj A. Medical management of cerebral edema. Neurosurg Focus. 2007;22(5):E12.
Bhardwaj A. Neurological impact of vasopressin dysregulation and hyponatremia. Ann Neurol. 2006;59:229–36.
Bhardwaj A, Ulatowski JA. Hypertonic saline solutions in brain injury. Curr Opin Crit Care. 2004;10:126–31.
Androgué HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;342:1581–9.
Bradshaw K, Smith M. Disorders of sodium balance after brain injury.: continuing education in anesthesia. Crit Care Pain. 2008;8(4):129–33.
Paredes-Andrade E, Solid C, Rockswold SB, et al. Hypertonic saline reduces intracranial hypertension in the presence of high serum and cerebrospinal fluid osmolalities. Neurocrit Care. 2011 Jul 2. Epub ahead of print.
Adamides AA, Winter CD, Lewis PM, et al. Current controversies in the management of patients with severe traumatic brain injury. ANZ J Surg. 2006;76:163–74.
• Hays AN, Lazaridis C, Neyens R, et al. Osmotherapy: use among neurointensivists. Neurocrit Care. 2011;14:222–8. This revealing survey of neurointensivists shows the current state of practice in osmotherapy, including how much study is needed to come together as a practice.
Androgue HJ, Madias NE. Hypernatremia. NEJM. 2000;342(20):1493–9.
Antunes-Rodrigues J, de Castro M, Elias LL, et al. Neuroendocrine control of body fluid metabolism. Physiol Rev. 2004;84:169–208.
• Kim DK, Joo KW. Hyponatremia in patients with neurologic disorders. Electrolyte Blood Press. 2009;7:51–7. A timely and relevant review for a common problem in neurologic patients.
Tomasino C. Volume and electrolyte management. Best Pract Res Anesthesiol. 2007;21(4):497–516.
Rabinstein AA, Bruder N. Management of hyponatremia and volume contraction. Neurocrit Care. 2011;15(2):354–60.
Nathan BR. Cerebral correlates of hyponatremia. Neurocrit Care. 2007;06:72–8.
Wright WL, Asbury WH, Gilmore JL, et al. Conivaptan for hyponatremia in the neurocritical care unit. Neurocrit Care. 2009;11(1):6–13.
Sterns RH, Silver SM. Brain volume regulation in response to hypo-osmolality and its correction. Am J Med. 2006;119:S12–6.
Sterns RH, Cappuccio JD, Silver SM, et al. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J Am Soc Nephrol. 1994;1522.
Froelich M, Ni Q, Wess C, et al. Continuous hypertonic saline therapy and the occurrence of complications in neurocritically ill patients. Crit Care Med. 2009;37:1433–41.
Parra A: “Hypertonic Saline,” adult neurocritical care protocols. Revision 04/01/2010. www.universityhealthsystem.com
Koenig M. Cerebral edema and intracranial hypertension. In: Bhardwaj A, Mirski MA, editors. Handbook of neurocritical care. 2nd ed. New York: Springer; 2011. p. 73–88.
Koenig MA, Bryan M, Lewin JL, et al. Reversal of transtentorial herniation with hypertonic saline. Neurology. 2008;70:1023–9.
• Woo CH, Rao VA, Sheridan W, et al. Performance characteristics of a sliding-scale hypertonic saline infusion protocol for the treatment of acute neurologic hyponatremia. Neurocrit Care. 2009;11:228–34. A novel approach to administering hypertonic saline, this sliding-scale method was well studied and may provide guidance for novel users.
Keyrouz SG, Dhar R, Diringer MN. Variation in osmotic response to sustained mannitol administration. Neurocrit Care. 2008;9:204–9.
Bardutzky J, Schwab S. Antiedema therapy in ischemic stroke. Stroke. 2007;38:3084–94.
Murphy T, Dhar R, Diringer M. Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit. Neurocrit Care. 2009;11(1):14–9.
Dhar R, Murphy-Human T. A bolus of conivaptan lowers intracranial pressure in a patient with hyponatremia after traumatic brain injury. Neurocrit Care. 2010;14:97–102.
Naidech AM, Paparello J, Leibling SM. Use of conivaptan (Vaprisol) for hyponatremic neuro-ICU patients. Neurocrit Care. 2010;13:57–61.
Disclosure
Conflicts of interest: W.L. Wright: participated in an advisory board for Astellas Pharma with the purpose of generating research project ideas within the last 36 months.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wright, W.L. Sodium and Fluid Management in Acute Brain Injury. Curr Neurol Neurosci Rep 12, 466–473 (2012). https://doi.org/10.1007/s11910-012-0284-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11910-012-0284-5